Sensex regains strength, rises over 150 points ahead of no-confidence motion in Lok Sabha today; Nifty reclaims 11,000 mark
Sensex which had lost 168.73 points in the previous two sessions, was trading higher by 158.11 points or 0.43%, at 36,509.34.
Mumbai: Domestic bourses recovered after falling for two straight sessions in early trade today as the benchmark Sensex recovered over 150 points driven by a fresh round of buying ahead of the no-confidence debate in Lok Sabha today.
Besides, persistent buying by domestic institutional investors (DIIs) too influenced sentiment.
The 30-share index, which had lost 168.73 points in the previous two sessions, was trading higher by 158.11 points, or 0.43 percent, at 36,509.34.
Sectoral indices led by IT, tech, capital goods, auto and banking stocks helped the recovery, rising by up to 1.31 percent.
The 50-share NSE Nifty reclaimed the 11,000 mark, quoting higher by 43.45 points, or 0.39 percent, at 11,000.55.
Major gainers in the Sensex pack were ICICI Bank, Infosys, Adani Ports, RIL, L&T, Axis Bank, Tata Steel, Wipro, SBI, TCS, Hero MotoCorp, SunPharma, Maruti Suzuki and ITC, rising up to 2.30 percent.
Meanwhile, DIIs bought shares worth a net of Rs 470.02 crore yesterday, while foreign portfolio investors (FPIs) sold shares to the tune of Rs 315.69 crore, as per stock exchanges' data.
Brokers said, expectations of the Modi government winning the first no-confidence motion it's facing in four years in the Lok Sabha boosted investor sentiment.
However, a weak trend in other Asian markets after China allowed its yuan currency to slide further, forced investors on the domestic bourses to adopt a cautious approach, they added.
Meanwhile, following yuan's fall, the rupee plunged to record low of 69.12 (intra-day) against the dollar at the forex market today.
Elsewhere in Asia, Shanghai Composite Index shed 0.12 per cent, while Hong Kong's Hang Seng was down 0.60 percent. Japan's Nikkei too fell 0.71 percent.
The US Dow Jones Industrial Average ended 0.53 percent down yesterday.
The trailer of Atrangi Re will release tomorrow, 24 November
The company has received approvals from ethics committees and is registered with CTRI for clinical trials of the nasal spray, which is designed to arrest the virus at the entry point in the nasal cavity
Why Hero MotoCorp will not make an electric motorcycle anytime soon, and will instead focus on e-scooters
Given the existing limitations presented by lithium-ion battery technology and high costs, Hero MotoCorp believes pure electric motorcycles are “way off”.